Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AsiaStrategy (SORA) Cash & Equivalents (2023 - 2025)

AsiaStrategy (SORA) has disclosed Cash & Equivalents for 3 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 44.54% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $1.5 million, down 44.54%, while the annual FY2025 figure was $1.5 million, 44.54% down from the prior year.
  • Cash & Equivalents hit $1.5 million in Q4 2025 for AsiaStrategy, down from $2.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.6 million in Q4 2024 and bottomed at $1.1 million in Q4 2023.
  • Average Cash & Equivalents over 3 years is $1.7 million, with a median of $1.5 million recorded in 2025.
  • Year-over-year, Cash & Equivalents skyrocketed 135.73% in 2024 and then plummeted 44.54% in 2025.
  • AsiaStrategy's Cash & Equivalents stood at $1.1 million in 2023, then surged by 135.73% to $2.6 million in 2024, then tumbled by 44.54% to $1.5 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $1.5 million, $2.6 million, and $1.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.